Doctor Hashmat Sayed Zohori Bahrami

Steno Diabetes Center, Copenhagen, Herlev (Denmark)

Follow

Contributor content

Inflammatory biomarkers suPAR, IL-6, and hsCRP and 13-year risk of mortality and MACE in type 2 diabetes: a prospective cohort study

Presentation

Inflammatory biomarkers suPAR, IL-6, and hsCRP and 13-year risk of mortality and MACE in type 2 diabetes: a prospective cohort study

Interleukin-6 and suPAR improves prediction of all-cause mortality in type 1 diabetes - the Thousand & 1 Study

Presentation

Interleukin-6 and suPAR improves prediction of all-cause mortality in type 1 diabetes - the Thousand & 1 Study

Interleukin-6 and suPAR are associated with diastolic function in type 1 diabetes: The Thousand & 1 Study

Presentation

Interleukin-6 and suPAR are associated with diastolic function in type 1 diabetes: The Thousand & 1 Study

Myocardial performance index improves prediction of major adverse cardiovascular events and heart failure in type 1 and type 2 diabetes without known heart disease: Thousand&1 and Thousand&2 study

Presentation

Myocardial performance index improves prediction of major adverse cardiovascular events and heart failure in type 1 and type 2 diabetes without known heart disease: Thousand&1 and Thousand&2 study

First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure - impact on diastolic function

Presentation

First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure - impact on diastolic function

Heart failure in survivors of out-of-hospital cardiac arrest - factors associated with reduced systolic ventricular function at follow-up

Presentation

Heart failure in survivors of out-of-hospital cardiac arrest - factors associated with reduced systolic ventricular function at follow-up

ESC 365 is supported by

novartis

Explore sponsored resources